Search results
Results From The WOW.Com Content Network
The first human case in the United States was on 21 January 2020. The World Health Organization declared the COVID-19 outbreak a Public Health Emergency of International Concern (PHEIC) on 30 January 2020, and first referred to it as a pandemic on 11 March 2020. [3] [4] The WHO ended the PHEIC on 5 May 2023. [5]
The UK Covid-19 Inquiry is an ongoing, independent public inquiry into the United Kingdom's response to, and the impact of, the COVID-19 pandemic, and to learn lessons for the future. Public hearings began in June 2023. Boris Johnson announced the inquiry in May 2021, to start in Spring 2022.
The Health Protection (Coronavirus, Restrictions) (Steps) (England) Regulations 2021 (SI 2021/364) is an English emergency statutory instrument which replaced the Health Protection (Coronavirus, Restrictions) (All Tiers) (England) Regulations 2020 from 29 March 2021. Initially, all of England was subject to Step 1 restrictions.
On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age. [20] [21] On 21 October 2021, India completed administering of one billion Covid vaccines in the country. [22]
At 3 p.m. on the same day, the Beijing Municipal Health Commission reported that from 21:00 on the 26th to 9:00 on 27 January, Beijing had four new cases of pneumonia infected with the new coronavirus, of which one was a close contact of the previously confirmed case.
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
COVID-19 drug development is the research process to develop preventative therapeutic prescription drugs that would alleviate the severity of coronavirus disease 2019 (COVID-19).
In April 2022, Denmark announced the suspension of its COVID-19 vaccination program, making it the first country in the world to do so. As of October 2022 the Danish Health Authorities recommend a booster vaccination to people aged 50 and over, as well as selected risk groups.